NasdaqCM - Delayed Quote USD
Benitec Biopharma Inc. (BNTC)
13.66
-0.12
(-0.91%)
At close: 4:00:01 PM EDT
13.66
0.00
(0.00%)
After hours: 4:05:08 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 750.68k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.63 - 13.22 per share. | Indirect | 211,736 | Mar 31, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.00 per share. | Indirect | 11,700,000 | Mar 26, 2025 |
| BUCHI J. KEVIN Director | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 12, 2025 |
| BUCHI J. KEVIN Director | Conversion of Exercise of derivative security at price 3.86 per share. | Direct | 199,998 | Feb 27, 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 10.98 - 11.25 per share. | Indirect | 527,174 | Dec 24, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 9.60 per share. | Indirect | 403,200 | Dec 3, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 9.73 - 10.22 per share. | Indirect | 416,616 | Nov 20, 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 0.00 - 3.86 per share. | Indirect | 21,135,373 | Sep 26, 2024 |
| BUCHI J. KEVIN Director | Purchase at price 2.81 per share. | Direct | 145,595 | Aug 11, 2023 |
| BOSTON MEGAN JOAN Officer and Director | Purchase at price 2.81 per share. | Direct | 72,799 | Aug 11, 2023 |
Related Tickers
J7Z.HA Jazz Pharmaceuticals PLC
92.50
+4.57%
J7Z.DU Jazz Pharmaceuticals PLC
93.20
+5.38%
J7Z.MU Jazz Pharmaceuticals PLC
91.48
+2.24%
CMXHF CSL Limited
153.34
+0.22%
J7Z.F Jazz Pharmaceuticals plc
91.94
+2.09%
GDTC CytoMed Therapeutics Limited
2.3992
+3.41%
CSLLY CSL Limited
76.40
-0.05%
XBIO Xenetic Biosciences, Inc.
2.5500
+6.69%
IRD Opus Genetics, Inc.
0.7599
+3.49%
PHGE BiomX Inc.
0.5910
+5.72%